Loading
Total declarations
Companies
▲ Purchases (17 ops.)
▼ Sales (1 ops.)
Latest filing published 26 Jun 2023 for Roivant Sciences Ltd., €118.6M. Read the official filing
Filing timeline
BuySaleSumitomo Chemical Co., Ltd.
Insider track record
Disclosed buys
17
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sumitomo Chemical Co., Ltd.: trading record in brief
Sumitomo Chemical Co., Ltd. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Myovant Sciences Ltd. and Roivant Sciences Ltd. Over a trading history stretching from 16 August 2021 to 22 June 2023, the count stands at 19 filings.
The open-market side counts 17 purchases for €1.3B alongside 1 sale for €118.6M. Purchases outweigh sales by €1.2B. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2023, the count stands at 1 purchase and 1 sale.
Half of the purchases are above €771k and half below. No cluster: in 17 purchases, no other insider of the company bought within 30 days.
The record was last updated on 26 June 2023 with an open-market sale (€118.6M) in Roivant Sciences Ltd. The latest purchase dates back some time: it was published 1,318 days ago, on 10 March 2023. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sumitomo Chemical Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
15,116,277 shares@ US$8.60100.0% of flowCommon SharesSEC:0000899243-23-016487:0
51,599,200 shares@ US$27.0098.1% of flowCommon SharesSEC:0000899243-23-007864:0
Canonical exit: 8 Jun 2023 (T+90)
4,243,005 shares0Common SharesSEC:0000899243-23-007110:0
20,677 shares@ US$22.84580.0% of flowCommon StockSEC:0000899243-21-038387:0
Canonical exit: 27 Dec 2021 (T+90)
36,000 shares@ US$23.40410.1% of flowCommon StockSEC:0000899243-21-038083:0
Canonical exit: 23 Dec 2021 (T+90)
84,018 shares@ US$21.95970.1% of flowCommon StockSEC:0000899243-21-037631:0
Canonical exit: 21 Dec 2021 (T+90)
38,273 shares@ US$22.09570.1% of flowCommon StockSEC:0000899243-21-037114:0
Canonical exit: 19 Dec 2021 (T+90)
50,000 shares@ US$21.7510.1% of flowCommon StockSEC:0000899243-21-036597:0
Canonical exit: 15 Dec 2021 (T+90)
65,128 shares@ US$22.03720.1% of flowCommon StockSEC:0000899243-21-036290:0
Canonical exit: 13 Dec 2021 (T+90)
30,000 shares@ US$25.1130.0% of flowCommon StockSEC:0000899243-21-035821:0
Canonical exit: 9 Dec 2021 (T+90)
21,902 shares@ US$25.73570.0% of flowCommon StockSEC:0000899243-21-035564:0
Canonical exit: 7 Dec 2021 (T+90)
29,822 shares@ US$26.73810.1% of flowCommon StockSEC:0000899243-21-035342:0
Canonical exit: 2 Dec 2021 (T+90)
40,000 shares@ US$24.82570.1% of flowCommon StockSEC:0000899243-21-035135:0
Canonical exit: 30 Nov 2021 (T+90)
70,000 shares@ US$23.91570.1% of flowCommon StockSEC:0000899243-21-034765:0
Canonical exit: 28 Nov 2021 (T+90)
40,000 shares@ US$22.67280.1% of flowCommon StockSEC:0000899243-21-034525:0
Canonical exit: 24 Nov 2021 (T+90)
34,299 shares@ US$22.370.0% of flowCommon StockSEC:0000899243-21-034281:0
Canonical exit: 22 Nov 2021 (T+90)
46,478 shares@ US$20.86020.1% of flowCommon StockSEC:0000899243-21-034046:0
Canonical exit: 18 Nov 2021 (T+90)
17,116 shares@ US$21.44730.0% of flowCommon StockSEC:0000899243-21-033840:0
Canonical exit: 16 Nov 2021 (T+90)
42,785 shares@ US$21.29380.1% of flowCommon StockSEC:0000899243-21-033476:0
Canonical exit: 14 Nov 2021 (T+90)
19 of 19 declarations
